Joint investments cover R&D, achieving EPA regulatory approval in the US and more
Swedish biotech firm I-Tech – developer of Selektope, an active agent that prevents barnacle attachment on ships, boat hulls and other marine installations – has signed a long-term collaboration agreement with a well-known supplier of high-performance antifouling paints to the leisure boat markets in North, Central, and South America.
To continue reading, please see the IBI Plus subscription options below for accessing our Premium Content.
You must be a subscriber and signed-in to access this content.
Benefits include:
to gain access to IBI Plus Premium content.
Alternatively, REGISTER to receive IBI Daily News & Breaking News alerts for free.
Already a subscriber? Sign-in now at the top of this page.